SEC Company Response from Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083) (SNOA) — Oct 29, 2010

Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083)
Date: Oct. 29, 2010 · CIK: 0001367083 · Accession: 0001144204-10-056539

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-33216

Date

March 31, 2010

Author

Jim Schutz

Form

CORRESP

Company

Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083)

Letter

United States Securities and Exchange Commission Division of Corporate Finance Oculus Innovative Sciences, Inc. Form 10-K for the fiscal year ended March 31, 2010 Filed June 8, 2010 File No. 001-33216

Dear Ms. Hogue:

In response to comments received from the staff of the Securities and Exchange Commission (the “Staff”) on the Form 10-K for the fiscal year ended March 31, 2010, the undersigned, being the Chief Operating Officer and General Counsel of Oculus Innovative Sciences, Inc., hereby certifies the following:

Oculus Innovative Sciences, Inc. is responsible for both the adequacy and accuracy of the disclosure in the Form 10-K filed June 8, 2010;

Oculus Innovative Sciences, Inc. acknowledges that the Staff comments or changes made in response to Staff comments do not foreclose the Commission from taking any action with respect to the Form 10-K; and

Oculus Innovative Sciences, Inc. acknowledges that it may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

/s/ Jim Schutz

Jim Schutz

Chief Operating Officer and General Counsel

Date: October 29, 2010

Show Raw Text

CORRESP
1
filename1.htm

    Unassociated Document

    October
29, 2010

    United
States Securities and Exchange Commission

    Division
of Corporate Finance

    100 F
Street, N.E., Mail Stop 3030

    Washington,
D.C. 20549

              Attn:

              Aslynn
      Hogue

              Re:

              Oculus
      Innovative Sciences, Inc.

    Form 10-K for the fiscal year ended
March 31, 2010

    Filed June 8, 2010

    File No. 001-33216

    Dear Ms.
Hogue:

    In
response to comments received from the staff of the Securities and Exchange
Commission (the “Staff”) on the Form 10-K for the fiscal year ended March 31,
2010, the undersigned, being the Chief
Operating Officer and General Counsel of Oculus Innovative Sciences,
Inc., hereby certifies the following:

              ·

              Oculus
      Innovative Sciences, Inc. is responsible for both the adequacy and
      accuracy of the disclosure in the Form 10-K filed June 8,
      2010;

              ·

              Oculus
      Innovative Sciences, Inc. acknowledges that the Staff comments or changes
      made in response to Staff comments do not foreclose the Commission from
      taking any action with respect to the Form 10-K;
  and

              ·

              Oculus
      Innovative Sciences, Inc. acknowledges that it may not assert Staff
      comments as a defense in any proceeding initiated by the Commission or any
      person under the federal securities laws of the United
    States.

                   /s/ Jim Schutz

                  Jim
      Schutz

                    Chief
      Operating Officer and General Counsel

                  Date:  October
      29, 2010

SecProbe.io